Singel, Kelly L.
Grzankowski, Kassondra S.
Khan, A. N. M. Nazmul H.
Grimm, Melissa J.
D’Auria, Anthony C.
Morrell, Kayla
Eng, Kevin H.
Hylander, Bonnie
Mayor, Paul C.
Emmons, Tiffany R.
Lénárt, Nikolett
Fekete, Rebeka
Környei, Zsuzsanna
Muthukrishnan, Uma
Gilthorpe, Jonathan D.
Urban, Constantin F.
Itagaki, Kiyoshi
Hauser, Carl J.
Leifer, Cynthia
Moysich, Kirsten B.
Odunsi, Kunle
Dénes, Ádám
Segal, Brahm H.
Funding for this research was provided by:
Roswell Park Cancer Institute (T32CA085183, 5T32CA108456, K01LM012100, 5T32CA108456, R01CA188900, P50CA159981, P50CA159981, P30CA016056, P50CA159981, R01CA188900)
Article History
Received: 24 July 2018
Revised: 9 October 2018
Accepted: 25 October 2018
First Online: 6 December 2018
Competing interests
: The authors declare no competing interests.
: This study was approved by the Institutional Review Board of Roswell Park Comprehensive Cancer Center (Roswell Park), Buffalo, NY, and was in compliance with federal and state requirements. All participants gave informed consent to use samples for research (protocols i215512 and i188310). All studies were conducted in compliance with the Declaration of Helsinki. Mice were bred and maintained under specific pathogen-free conditions at the animal care facility at Roswell Park and used in compliance with all relevant laws and institutional guidelines under a protocol approved by the Institutional Animal Care and Use Committee.